glp 1 drugs ozempic in 8 adults in the US has taken or another GLP-1 drug, KFF survey finds GLP-1 Drugs | Association of

Nature Medicine

Both medicines are prescribed within structured pathways and are not suitable for everyone

This is particularly noteworthy because two competing oral small-molecule GLP-1 programs from Pfizer, lotiglipron (discontinued in 2023) and danuglipron (discontinued in April 2025), were terminated due to liver toxicity concerns

Accessed April 8, 2017

After ingestion of a meal, GLP-1 is secreted by intestinal L cells and acts on a cognate receptor within the pancreas to stimulate insulin release, while neuronal pathways also contribute to GLP-1s insulinotropic actions

The most common side effects include nausea, vomiting, and diarrhea, which can subside as the body adjusts to the medication but some people report each time they take an injection there are miserable days they just try and endure